期刊
LEUKEMIA
卷 36, 期 9, 页码 2328-2337出版社
SPRINGERNATURE
DOI: 10.1038/s41375-022-01636-8
关键词
-
资金
- National Heart, Lung, and Blood Institute
- Novartis via a CRADA
This study assessed predictors, genetic characteristics, and long-term outcomes of patients with severe aplastic anemia (SAA) who experienced clonal evolution after immunosuppressive therapy (IST). High-risk evolution was associated with older age and higher ANC levels. Patients with high-risk clonal evolution had lower overall survival rates, but those who underwent hematopoietic stem cell transplant (HSCT) showed improved survival. Certain gene mutations detected at 6 months after IST were predictive of high-risk evolution.
Predictors, genetic characteristics, and long-term outcomes of patients with SAA who clonally evolved after immunosuppressive therapy (IST) were assessed. SAA patients were treated with IST from 1989-2020. Clonal evolution was categorized as high-risk (overt myeloid neoplasm [meeting WHO criteria for dysplasia, MPN or acute leukemia] or isolated chromosome-7 abnormality/complex karyotype without dysplasia or overt myeloid neoplasia) or low-risk (non-7 or non-complex chromosome abnormalities without morphological evidence of dysplasia or myeloid neoplasia). Univariate and multivariate analysis using Fine-Gray competing risk regression model determined predictors. Long-term outcomes included relapse, overall survival (OS) and hematopoietic stem cell transplant (HSCT). Somatic mutations in myeloid cancer genes were assessed in evolvers and in 407 patients 6 months after IST. Of 663 SAA patients, 95 developed clonal evolution. Pre-treatment age >48 years and ANC > 0.87 x 10(9)/L were strong predictors of high-risk evolution. OS was 37% in high-risk clonal evolution by 5 years compared to 94% in low-risk. High-risk patients who underwent HSCT had improved OS. Eltrombopag did not increase high-risk evolution. Splicing factors and RUNX1 somatic variants were detected exclusively at high-risk evolution; DNMT3A, BCOR/L1 and ASXL1 were present in both. RUNX1, splicing factors and ASXL1 somatic mutations detected at 6 months after IST predicted high-risk evolution.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据